A PPARα Promoter Variant Impairs ERR-Dependent Transactivation and Decreases Mortality after Acute Coronary Ischemia in Patients with Diabetes

• Sharon Cresci ,

  * E-mail: scresci@dom.wustl.edu

  Affiliation Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri, United States of America

  ⨯
• Janice M. Huss,

  Affiliation City of Hope National Medical Center, Duarte, California, United States of America

  ⨯
• Amber L. Beitelshees,

  Affiliation University of Maryland, Baltimore, Maryland, United States of America

  ⨯
• Philip G. Jones,

  Affiliation Saint Luke's Mid America Heart Institute and the University of Missouri-Kansas City, Kansas City, Missouri, United States of America

  ⨯
• Matt R. Minton,

  Affiliation Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri, United States of America

  ⨯
• Gerald W. Dorn II,

  Affiliation Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri, United States of America

  ⨯
• Daniel P. Kelly,

  Affiliation Burnham Institute for Medical Research, Orlando, Florida, United States of America

  ⨯
• John A. Spertus,

  Affiliation Saint Luke's Mid America Heart Institute and the University of Missouri-Kansas City, Kansas City, Missouri, United States of America

  ⨯
• Howard L. McLeod

  Affiliation University of North Carolina Institute for Pharmacogenomics and Individualized Therapy, Chapel Hill, North Carolina, United States of America

  ⨯